Nalu Medical picks up $50M in growth funding

Trinity Capital announced that it committed up to $50 million in growth funding to neurostimulation technology developer Nalu Medical.

Carlsbad, California–based Nalu offers spinal cord stimulation and peripheral nerve stimulation (PNS) technology. It designed its offerings to treat patients with chronic neuropathic pain. It delivers gentle electrical pulses to the nervous system to modulate pain signals before they reach the brain.

“We are proud to partner with and support Nalu as they advance the care of patients with chronic neuropathic pain,” said Rob Lake, senior managing director of Life Sciences at Trinity Capital. “We believe Nalu is a leader in PNS and is reshaping the pain management landscape through their innovative technology and robust clinical data.”

See full article (https://www.massdevice.com/nalu-medical-50m-growth-funding/)